ESG Survey Index
* Items with an asterisk are part of the Asahi Kasei Group's ESH & QA Activities.
Subject | Policy | Management System | Initiatives | |
---|---|---|---|---|
ESH & QA Activities | ● | ● | ● | |
E | Climate Change* | ● | ● | ● |
Disclosure based on TCFD Recommendations | ● | |||
Pollution & Resources* | ● | ● | ● | |
Water Use* | ● | ● | ● | |
Biodiversity* | ● | ● | ● | |
Supply Chain (Environmental)* | ● | ● | ● | |
S | Customer Responsibility | ● | ||
Quality Assurance* | ● | ● | ● | |
Labor Standards | ● | ● | ● | |
Occupational Health and Safety* | ● | ● | ||
Health and Productivity Management* | ● | ● | ● | |
Human Rights | ● | ● | ||
Community | ● | ● | ● | |
Social Contributions | ● | ● | ||
Supply Chain (Social) | ● | ● | ● | |
G | Corporate Governance | Basic Views | ● | |
Corporate Governance Framework | ● | |||
Policy and Procedures for Nomination of Director Candidates | ● | |||
Directors | ● | |||
Attendance Rate at Board Meetings | ● | |||
Evaluation of Board Effectiveness | ● | |||
Officer Compensation | ● | |||
Independence Standards for Outside Officers | ● | |||
Status of Audit & Supervisory Board Member Audits, Accounting Audits and Internal Audits | ● | |||
Compliance | Policy | ● | ||
Management Framework | ● | |||
Whistleblower System | ● | |||
Prevention of Corruption and Bribery | ● | |||
Political Contributions | ● | |||
Compliance with Anti-trust Laws and Competition Laws | ● | |||
Initiatives for Transparency in Relationships with Medical Institutions | ● | |||
Ethical Considerations in Pharmaceuticals and Medical Device Development | ● | |||
Risk Management | Policy | ● | ||
Management Framework | ● | |||
Information Security | ● | |||
Protection of Personal Information | ● | |||
Protection of Intellectual Property | ● | |||
Emergency Response | ● | |||
Tax Policy | Tax Policy | ● | ||
ESG Data List | ESG-related data is shown | ● |